Sign in

Publication

Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland

Journal Paper/Review - Dec 27, 2019

Bhadhuri Arjun, Insinga Ralph, Guggisberg Patrik, Panje Cédric, Schwenkglenks Matthias

Bhadhuri, Arjun
1
0
Insinga, Ralph
1
0
Guggisberg, Patrik
1
0
Panje, Cédric
31
3
Schwenkglenks, Matthias
13
0

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy